Dyne Therapeutics Company
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Connections from
Funding Status:
IPO
Industry:
PharmTech
Founded Date:
1/1/2018
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
333000000
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50